Sandra Moore

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Ross L. Levine, Martha Wadleigh, Jan Cools et al. · Cancer Cell · 2005 · 3K citations · Full text

Medicine, Genetics, Hematology +14

MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

Yana Pikman, Benjamin H. Lee, Thomas Mercher et al. · PLoS Medicine · 2006 · 1.4K citations · Full text

Life Sciences, Genetics, Hematology +14

Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera

Gerlinde Wernig, Michael G. Kharas, Rachel Okabe et al. · Cancer Cell · 2008 · 384 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

Activating alleles of JAK3 in acute megakaryoblastic leukemia

Denise K. Walters, Thomas Mercher, Ting-Lei Gu et al. · Cancer Cell · 2006 · 314 citations

Life Sciences, Genetics, Hematology +9

Notch Signaling Specifies Megakaryocyte Development from Hematopoietic Stem Cells

Thomas Mercher, Melanie Cornejo, Christopher Sears et al. · Cell stem cell · 2008 · 134 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +14